NCT05486234 CARS: Cannabis and Alcohol Reduction Study
| NCT ID | NCT05486234 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of South Carolina |
| Condition | Cannabis Use |
| Study Type | INTERVENTIONAL |
| Enrollment | 52 participants |
| Start Date | 2023-01-25 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 52 participants in total. It began in 2023-01-25 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will test a computerized treatment with subjects ages 13-17 years who are seeking treatment for alcohol and/or cannabis use. Follow-up assessments will be conducted at one- and three-months following treatment.
Eligibility Criteria
Inclusion Criteria: * between the ages of 13 and 17 * be seeking treatment for either cannabis or alcohol use; * report co-occurring alcohol and cannabis use during the past three months (i.e., participants who report using both alcohol and cannabis during the three months prior to participation in the study, regardless of if the use was simultaneous) * have a caregiver willing to participate and provide consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05486234 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 17 Years, studying Cannabis Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05486234 currently recruiting?
Yes, NCT05486234 is actively recruiting participants. Contact the research team at hahna@musc.edu for enrollment information.
Where is the NCT05486234 trial being conducted?
This trial is being conducted at Charleston, United States.
Who is sponsoring the NCT05486234 clinical trial?
NCT05486234 is sponsored by Medical University of South Carolina. The trial plans to enroll 52 participants.